BDBM263551 3-(4-{5-amino-4-[5- (morpholine-4-carbonyl)-1h- benzoimidazole-2-carbonyl]- pyrazol-1-yl}-3-methyl- phenoxy)-benzonitrile::US9556150, i-39

SMILES Cc1cc(Oc2cccc(C#N)c2)ccc1-n1ncc(C(=O)c2nc3cc(C(=O)N4CCOCC4)ccc3[nH]2)c1N

InChI Key InChIKey=IFRBUGHFMWMQIE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 263551   

TargetTyrosine-protein kinase BTK(Human)
F. Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 263551BDBM263551(3-(4-{5-amino-4-[5- (morpholine-4-carbonyl)-1h- be...)
Affinity DataIC50: 24nMpH: 7.15Assay Description:This BTK competition assay measures compound potency (IC50) for the inactivated state of Bruton's Tyrosine Kinase using FRET (F rster/Fluorescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/8/2018
Entry Details
US Patent